QFVIX | VIHAX | QFVIX / VIHAX | |
Total Expense Ratio | 1.04 | 0.17 | 612% |
Annual Report Gross Expense Ratio | 1.26 | 0.17 | 741% |
Fund Existence | 26 years | 9 years | - |
Gain YTD | 2.818 | 7.752 | 36% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.12B | 9.54B | 22% |
Annual Yield % from dividends | 2.33 | 4.45 | 52% |
Returns for 1 year | 3.21 | 10.92 | 29% |
Returns for 3 years | 11.40 | 13.55 | 84% |
Returns for 5 years | 64.14 | 63.53 | 101% |
Returns for 10 years | 38.96 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BMSRX | 12.52 | 0.09 | +0.72% |
MFS Blended Research Mid Cap Eq R1 | |||
WAISX | 13.03 | 0.08 | +0.62% |
Wasatch International Select Investor | |||
TMITX | 9.01 | 0.04 | +0.45% |
Transamerica Mid Cap Growth I3 | |||
JLVRX | 18.53 | 0.02 | +0.11% |
JPMorgan Large Cap Value R5 | |||
MNHCX | 23.28 | 0.01 | +0.04% |
Manning & Napier Pro-Blend Max Term L |